{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T04:03:32Z","timestamp":1794456212325,"version":"4.9.1"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2020,10,15]],"date-time":"2020-10-15T00:00:00Z","timestamp":1602720000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,10,15]],"date-time":"2020-10-15T00:00:00Z","timestamp":1602720000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"name":"shire international GmbH","award":["IST-DNK-000718"],"award-info":[{"award-number":["IST-DNK-000718"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Endocrine"],"published-print":{"date-parts":[[2021,2]]},"DOI":"10.1007\/s12020-020-02507-x","type":"journal-article","created":{"date-parts":[[2020,10,15]],"date-time":"2020-10-15T19:02:36Z","timestamp":1602788556000},"page":"467-475","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["The effect of dual-release versus conventional hydrocortisone on fatigue, measured by ecological momentary assessments"],"prefix":"10.1007","volume":"71","author":[{"given":"Victor Brun","family":"Boesen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stina Willemoes","family":"Borresen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thea","family":"Christoffersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marianne","family":"Klose","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Torquil","family":"Watt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5903-3355","authenticated-orcid":false,"given":"Ulla","family":"Feldt-Rasmussen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,10,15]]},"reference":[{"key":"2507_CR1","doi-asserted-by":"publisher","first-page":"3954","DOI":"10.1210\/jc.2006-0524","volume":"91","author":"H Filipsson","year":"2006","unstructured":"H. Filipsson, J.P. Monson, M. Koltowska-H\u00e4ggstr\u00f6m, A. Mattsson, G. Johannsson, The impact of glucocorticoid replacement regimens on metabolic outcome and comorbidity in hypopituitary patients. J. Clin. Endocrinol. Metab. 91, 3954 (2006).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"2507_CR2","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1007\/BF03345773","volume":"32","author":"R Giordano","year":"2009","unstructured":"R. Giordano, S. Marzotti, M. Balbo, S. Romagnoli, E. Marinazzo, R. Berardelli, G. Migliaretti, A. Benso, A. Falorni, E. Ghigo, E. Arvat, Metabolic and cardiovascular profile in patients with Addison\u2019s disease under conventional glucocorticoid replacement. J. Endocrinol. Investig. 32, 917 (2009).","journal-title":"J. Endocrinol. Investig."},{"key":"2507_CR3","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1007\/s12020-010-9359-8","volume":"38","author":"L Leelarathna","year":"2010","unstructured":"L. Leelarathna, L. Breen, J.K. Powrie, S.M. Thomas, R. Guzder, B. McGowan, P.V. Carroll, Co-morbidities, management and clinical outcome of auto-immune Addison\u2019s disease. Endocrine 38, 113 (2010).","journal-title":"Endocrine"},{"key":"2507_CR4","doi-asserted-by":"publisher","first-page":"3691","DOI":"10.1210\/jc.2016-2216","volume":"101","author":"JW Buning","year":"2016","unstructured":"J.W. Buning, M.Van. Faassen, P. Brummelman, R.P.F. Dullaart, G. Van Den Berg, M.M. Van Der Klauw, M.N. Kerstens, C.A. Stegeman, A.C.M. Kobold, I.P. Kema, B.H.R. Wolffenbuttel, A.P.Van. Beek, Effects of hydrocortisone on the regulation of blood pressure: results from a randomized controlled trial. J. Clin. Endocrinol. Metab. 101, 3691 (2016).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"2507_CR5","doi-asserted-by":"publisher","first-page":"2152","DOI":"10.1016\/S0140-6736(13)61684-0","volume":"383","author":"E Charmandari","year":"2014","unstructured":"E. Charmandari, N.C. Nicolaides, G.P. Chrousos, Adrenal insufficiency. Lancet 383, 2152 (2014).","journal-title":"Lancet"},{"key":"2507_CR6","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1159\/000439329","volume":"30","author":"A Mallappa","year":"2016","unstructured":"A. Mallappa, M. Debono, Endocrine development: workshop, Rome, October 2014. Endocr. Dev. 30, 42 (2016).","journal-title":"Endocr. Dev."},{"key":"2507_CR7","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1210\/jc.2015-1710","volume":"101","author":"SR Bornstein","year":"2016","unstructured":"S.R. Bornstein, B. Allolio, W. Arlt, A. Barthel, A. Don-Wauchope, G.D. Hammer, E.S. Husebye, D.P. Merke, M.H. Murad, C.A. Stratakis, D.J. Torpy, Diagnosis and treatment of primary adrenal insufficiency: an endocrine society clinical practice guideline. J. Clin. Endocrinol. Metab. 101, 364 (2016).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"2507_CR8","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1046\/j.1365-2265.2002.01466.x","volume":"56","author":"K L\u00f8v\u00e5s","year":"2002","unstructured":"K. L\u00f8v\u00e5s, J.H. Loge, E.S. Husebye, Subjective health status in Norwegian patients with Addison\u2019s disease*: Subjective health status in Addison\u2019s disease. Clin. Endocrinol. (Oxf.) 56, 581 (2002).","journal-title":"Clin. Endocrinol. (Oxf.)"},{"key":"2507_CR9","doi-asserted-by":"publisher","first-page":"3912","DOI":"10.1210\/jc.2007-0685","volume":"92","author":"S Hahner","year":"2007","unstructured":"S. Hahner, M. Loeffler, M. Fassnacht, D. Weismann, A.C. Koschker, M. Quinkler, O. Decker, W. Arlt, B. Allolio, Impaired subjective health status in 256 patients with adrenal insufficiency on standard therapy based on cross-sectional analysis. J. Clin. Endocrinol. Metab. 92, 3912 (2007).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"2507_CR10","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1530\/EJE-08-0578","volume":"159","author":"B Bleicken","year":"2008","unstructured":"B. Bleicken, S. Hahner, M. Loeffler, M. Ventz, B. Allolio, M. Quinkler, Impaired subjective health status in chronic adrenal insufficiency: Impact of different glucocorticoid replacement regimens. Eur. J. Endocrinol. 159, 811 (2008).","journal-title":"Eur. J. Endocrinol."},{"key":"2507_CR11","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1111\/j.1365-2265.2009.03596.x","volume":"72","author":"B Bleicken","year":"2010","unstructured":"B. Bleicken, S. Hahner, M. Loeffler, M. Ventz, O. Decker, B. Allolio, M. Quinkler, Influence of hydrocortisone dosage scheme on health-related quality of life in patients with adrenal insufficiency. Clin. Endocrinol. (Oxf.) 72, 297 (2010).","journal-title":"Clin. Endocrinol. (Oxf.)"},{"key":"2507_CR12","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/1472-6823-12-8","volume":"12","author":"M Forss","year":"2012","unstructured":"M. Forss, G. Batcheller, S. Skrtic, G. Johannsson, Current practice of glucocorticoid replacement therapy and patient-perceived health outcomes in adrenal insufficiency-a worldwide patient survey. BMC Endocr. Disord. 12, 8 (2012).","journal-title":"BMC Endocr. Disord."},{"key":"2507_CR13","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1210\/jc.2011-1926","volume":"97","author":"G Johannsson","year":"2012","unstructured":"G. Johannsson, A.G. Nilsson, R. Bergthorsdottir, P. Burman, P. Dahlqvist, B. Ekman, B.E. Engstr\u00f6m, T. Olsson, O. Ragnarsson, M. Ryberg, J. Wahlberg, B.M.K. Biller, J.P. Monson, P.M. Stewart, H. Lennern\u00e4s, S. Skrtic, Improved cortisol exposure-time profile and outcome in patients with adrenal insufficiency: a prospective randomized trial of a novel hydrocortisone dual-release formulation. J. Clin. Endocrinol. Metab. 97, 473 (2012).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"2507_CR14","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1111\/cen.13554","volume":"88","author":"V Guarnotta","year":"2018","unstructured":"V. Guarnotta, A. Ciresi, G. Pillitteri, C. Giordano, Improved insulin sensitivity and secretion in prediabetic patients with adrenal insufficiency on dual-release hydrocortisone treatment: a 36-month retrospective analysis. Clin. Endocrinol. (Oxf.). 88, 665 (2018).","journal-title":"Clin. Endocrinol. (Oxf.)."},{"key":"2507_CR15","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1530\/EC-19-0176","volume":"8","author":"V Guarnotta","year":"2019","unstructured":"V. Guarnotta, C. Di Stefano, A. Santoro, A. Ciresi, A. Coppola, C. Giordano, Dual-release hydrocortisone vs conventional glucocorticoids in adrenal insufficiency. Endocr. Connect. 8, 853 (2019).","journal-title":"Endocr. Connect."},{"key":"2507_CR16","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1007\/s12020-015-0681-z","volume":"51","author":"R Giordano","year":"2016","unstructured":"R. Giordano, F. Guaraldi, E. Marinazzo, F. Fumarola, A. Rampino, R. Berardelli, I. Karamouzis, M. Lucchiari, T. Manetta, G. Mengozzi, E. Arvat, E. Ghigo, Improvement of anthropometric and metabolic parameters, and quality of life following treatment with dual-release hydrocortisone in patients with Addison\u2019s disease. Endocrine 51, 360 (2016).","journal-title":"Endocrine"},{"key":"2507_CR17","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/S2213-8587(17)30398-4","volume":"6","author":"AM Isidori","year":"2018","unstructured":"A.M. Isidori, M.A. Venneri, C. Graziadio, C. Simeoli, D. Fiore, V. Hasenmajer, E. Sbardella, D. Gianfrilli, C. Pozza, P. Pasqualetti, S. Morrone, A. Santoni, F. Naro, A. Colao, R. Pivonello, A. Lenzi, Effect of once-daily, modified-release hydrocortisone versus standard glucocorticoid therapy on metabolism and innate immunity in patients with adrenal insufficiency (DREAM): a single-blind, randomised controlled trial. Lancet Diabetes Endocrinol. 6, 173 (2018).","journal-title":"Lancet Diabetes Endocrinol."},{"key":"2507_CR18","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1530\/EJE-14-1114","volume":"172","author":"M Quinkler","year":"2015","unstructured":"M. Quinkler, R.M. Nilsen, K. Zopf, M. Ventz, M. \u00d8ksnes, Modified-release hydrocortisone decreases BMI and HbA1c in patients with primary and secondary adrenal insufficiency. Eur. J. Endocrinol. 172, 619 (2015).","journal-title":"Eur. J. Endocrinol."},{"key":"2507_CR19","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1530\/EJE-17-0067","volume":"176","author":"AG Nilsson","year":"2017","unstructured":"A.G. Nilsson, R. Bergthorsdottir, P. Burman, P. Dahlqvist, B. Ekman, B.E. Engstr\u00f6m, O. Ragnarsson, S. Skrtic, J. Wahlberg, H. Achenbach, S. Uddin, C. Marelli, G. Johannsson, Long-Term safety of once-daily, dual-release hydrocortisone in patients with adrenal insufficiency: A phase 3b, open-label, extension study. Eur. J. Endocrinol. 176, 715 (2017).","journal-title":"Eur. J. Endocrinol."},{"key":"2507_CR20","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1530\/EC-18-0257","volume":"7","author":"F Ceccato","year":"2018","unstructured":"F. Ceccato, E. Selmin, C. Sabbadin, M. Dalla Costa, G. Antonelli, M. Plebani, M. Barbot, C. Betterle, M. Boscaro, C. Scaroni, Improved salivary cortisol rhythm with dual-release hydrocortisone. Endocr. Connect. 7, 965 (2018).","journal-title":"Endocr. Connect."},{"key":"2507_CR21","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1210\/jc.2011-1901","volume":"97","author":"M \u00d8ksnes","year":"2012","unstructured":"M. \u00d8ksnes, S. Bensing, A.L. Hulting, O. Kam\u0308pe, A. Hackemann, G. Meyer, K. Badenhoop, C. Betterle, A. Parolo, R. Giordano, A. Falorni, L. Papierska, W. Jeske, A.A. Kasperlik-Zaluska, V.K.K. Chatterjee, E.S. Husebye, K. L\u00f8vas, Quality of life in European patients with Addison\u2019s disease:Validity of the disease-specific questionnaire AddiQoL. J. Clin. Endocrinol. Metab. 97, 568 (2012).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"2507_CR22","doi-asserted-by":"crossref","unstructured":"A. Stone, S. Shiffman, A. Atienza, L. Nebeling, The science of real-time data capture: self-reports in health research (Oxford University Press, Oxford; 2007).","DOI":"10.1093\/oso\/9780195178715.001.0001"},{"key":"2507_CR23","doi-asserted-by":"publisher","first-page":"1561","DOI":"10.1089\/thy.2018.0210","volume":"28","author":"VB Boesen","year":"2018","unstructured":"V.B. Boesen, U. Feldt-Rasmussen, J. Bue Bjorner, P. Cramon, M. Groenvold, B. Nygaard, \u00c5.K. Rasmussen, T. Vilsb\u00f8ll, T. Watt, How should thyroid-related quality of life be assessed? Recalled patient-reported outcomes compared to here-and-now measures. Thyroid 28, 1561 (2018).","journal-title":"Thyroid"},{"key":"2507_CR24","doi-asserted-by":"publisher","first-page":"1654064","DOI":"10.1080\/20008198.2019.1654064","volume":"10","author":"P Lorenz","year":"2019","unstructured":"P. Lorenz, L. Schindler, S. Steudte-Schmiedgen, K. Weidner, C. Kirschbaum, J. Schellong, Ecological momentary assessment in posttraumatic stress disorder and coping. An eHealth study protocol. Eur. J. Psychotraumatol. 10, 1654064 (2019)","journal-title":"Eur. J. Psychotraumatol."},{"key":"2507_CR25","doi-asserted-by":"publisher","first-page":"3333","DOI":"10.1007\/s11136-019-02278-7","volume":"28","author":"P Solk","year":"2019","unstructured":"P. Solk, K. Gavin, J. Fanning, W. Welch, G. Lloyd, A. Cottrell, A. Nielsen, C.A.Santa. Maria, W. Gradishar, S.A. Khan, S. Kulkarni, J. Siddique, S.M. Phillips, Feasibility and acceptability of intensive longitudinal data collection of activity and patient-reported outcomes during chemotherapy for breast cancer. Qual. Life Res 28, 3333 (2019).","journal-title":"Qual. Life Res"},{"key":"2507_CR26","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1177\/1073191116643164","volume":"25","author":"MJ Sliwinski","year":"2018","unstructured":"M.J. Sliwinski, J.A. Mogle, J. Hyun, E. Munoz, J.M. Smyth, R.B. Lipton, Reliability and validity of ambulatory cognitive assessments. Assessment 25, 14 (2018).","journal-title":"Assessment"},{"key":"2507_CR27","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1016\/j.pain.2012.01.001","volume":"153","author":"S Schneider","year":"2012","unstructured":"S. Schneider, D.U. Junghaenel, F.J. Keefe, J.E. Schwartz, A.A. Stone, J.E. Broderick, Individual differences in the day-to-day variability of pain, fatigue, and well-being in patients with rheumatic disease: associations with psychological variables. Pain 153, 813 (2012).","journal-title":"Pain"},{"key":"2507_CR28","doi-asserted-by":"crossref","first-page":"19487","DOI":"10.1136\/bmjopen-2017-019487","volume":"8","author":"VB Boesen","year":"2018","unstructured":"V.B. Boesen, T. Christoffersen, T. Watt, S.W. Borresen, M. Klose, U. Feldt-Rasmussen, PlenadrEMA: effect of dual-release versus conventional hydrocortisone on fatigue, measured by ecological momentary assessments: a study protocol for an open-label switch pilot study. BMJ Open. 8, 19487 (2018).","journal-title":"BMJ Open."},{"key":"2507_CR29","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/0022-3999(94)00125-O","volume":"39","author":"EMA Smets","year":"1995","unstructured":"E.M.A. Smets, B. Garssen, B. Bonke, J.C.J.M. De Haes, The multidimensional fatigue inventory (MFI) psychometric qualities of an instrument to assess fatigue. J. Psychosom. Res. 39, 315 (1995).","journal-title":"J. Psychosom. Res."},{"key":"2507_CR30","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1177\/1740774513517778","volume":"11","author":"P Cramon","year":"2014","unstructured":"P. Cramon, \u00c5.K. Rasmussen, S.J. Bonnema, J.B. Bjorner, U. Feldt-Rasmussen, M. Groenvold, L. Heged\u00fcs, T. Watt, Development and implementation of PROgmatic: a clinical trial management system for pragmatic multi-centre trials, optimised for electronic data capture and patient-reported outcomes. Clin. Trials 11, 344 (2014).","journal-title":"Clin. Trials"},{"key":"2507_CR31","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1093\/clinids\/18.Supplement_1.S79","volume":"18","author":"JD Fisk","year":"1994","unstructured":"J.D. Fisk, P.G. Ritvo, L. Ross, D.A. Haase, T.J. Marrie, W.F. Schlech, Measuring the functional impact of fatigue: initial validation of the fatigue impact scale. Clin. Infect. Dis. 18, 79 (1994).","journal-title":"Clin. Infect. Dis."},{"key":"2507_CR32","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1097\/00005650-199206000-00002","volume":"30","author":"JE Ware","year":"1992","unstructured":"J.E. Ware, C.D. Sherbourne, The MOS 36-ltem short-form health survey (SF-36): I. Conceptual framework and item selection. Med. Care 30, 473 (1992).","journal-title":"Med. Care"},{"key":"2507_CR33","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1007\/s00520-009-0653-z","volume":"18","author":"A Purcell","year":"2010","unstructured":"A. Purcell, J. Fleming, S. Bennett, B. Burmeister, T. Haines, Determining the minimal clinically important difference criteria for the multidimensional fatigue inventory in a radiotherapy population. Support. Care Cancer 18, 307 (2010).","journal-title":"Support. Care Cancer"},{"key":"2507_CR34","doi-asserted-by":"crossref","unstructured":"J. Cohen, Statistical power analysis for the behavioral sciences (Taylor & Francis Inc, New York, 2013).","DOI":"10.4324\/9780203771587"},{"key":"2507_CR35","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1037\/1528-3542.6.1.139","volume":"6","author":"AA Stone","year":"2006","unstructured":"A.A. Stone, J.E. Schwartz, D. Schkade, N. Schwarz, A. Krueger, D. Kahneman, A population approach to the study of emotion: diurnal rhythms of a working day examined with the day reconstruction method. Emotion 6, 139 (2006).","journal-title":"Emotion"}],"container-title":["Endocrine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-020-02507-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12020-020-02507-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-020-02507-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,15]],"date-time":"2024-08-15T23:41:56Z","timestamp":1723765316000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12020-020-02507-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,15]]},"references-count":35,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,2]]}},"alternative-id":["2507"],"URL":"https:\/\/doi.org\/10.1007\/s12020-020-02507-x","relation":{},"ISSN":["1355-008X","1559-0100"],"issn-type":[{"value":"1355-008X","type":"print"},{"value":"1559-0100","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,15]]},"assertion":[{"value":"24 June 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 September 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 October 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The study was performed in accordance with the Declarations of Helsinki and monitored by the Good Clinical Practice unit at Rigshospitalet. The study was approved by the Regional Scientific Ethical Committee in Copenhagen (ID: H-1-2014-073), the Danish Medicines Agency (ID: 2014070658), and the Danish Data Protection Agency (local identifier at Rigshospitalet: 30\u20131233). The study was registered at the EudraCT database (2014-002039-32). Informed consent was obtained from all individual participants.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}